Rola Khedraki, M.D.
NPI 1326466707ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· La Jolla, CA
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in La Jolla, California, trained at University of Vermont College of Medicine (class of 2014). Their prescriptions cost Medicare Part D more than their services did: $4,130,186 for 1,047 claims, against $221,726 paid for services in 2024. Alnylam Pharmaceuticals Inc. was the largest of 14 companies reporting payments in 2025, $53,696 in all, mostly speaking and faculty fees.
Overview
| NPI | 1326466707 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Apr 2, 2014 |
| Last updated in NPPES | Mar 1, 2022 |
| Certified by provider | Mar 1, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | A140216 | CA |
| Internal Medicine | 207R00000X | A140216 | CA |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | A140216 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 2,034 |
|---|---|
| Services billed | 3,959 across 57 procedure codes |
| Paid by Medicare | $221,726 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,047 · 2,403 30-day fills |
|---|---|
| Patients | 175 |
| Total drug cost | $4,130,186 |
| Generic share | 60% of claims |
Education and affiliations
| Medical school | University of Vermont College of Medicine |
|---|---|
| Graduation year | 2014 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical group
- Scripps HealthLa Jolla, CA · 1,433 clinicians
Hospital affiliations
- Scripps Green HospitalLa Jolla, CA
- Scripps Memorial Hospital la JollaLa Jolla, CA
Industry payments (Open Payments)
- 2025$53,696 · 59 payments from 14 companies
- 2024$22,823 · 51 payments from 15 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $28,015 | 18 |
| Bridgebio Pharma, Inc. | $13,066 | 2 |
| Kestra Medical Technology Services, Inc. | $4,407 | 2 |
| Astrazeneca Pharmaceuticals LP | $4,143 | 5 |
| Pfizer Inc. | $1,553 | 5 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$28,683 · 10 payments
- Consulting Fee$21,883 · 8 payments
- Travel and Lodging$1,830 · 7 payments
- Food and Beverage$1,301 · 34 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in La Jolla
- 1285612457
- 1346515442
- 1285165084
- 1124523147
- 1841453081
- 1518586171
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in California →